Source link : https://newshealth.biz/health-news/next-generation-tki-approved-for-advanced-ros1-positive-lung-cancer/
(MedPage Today) — The FDA approved taletrectinib (Ibtrozi) — a next-generation oral ROS1 tyrosine kinase inhibitor (TKI) — for the treatment of adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC)… Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/116021 Author : Publish date : 2025-06-11 20:19:00 Copyright for syndicated content belongs to the linked Source.
The post Next-Generation TKI Approved for Advanced ROS1-Positive Lung Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-11 20:19:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8